Abstract
IN the first fortnight of the War (1939) fundamental research was initiated in the Oxford Department of Biochemistry by Peters and carried out under his direction by a group of workers as an extra-mural research with the support of and for the Chemical Defence Research Department, Ministry of Supply; the object was to find antidotes for vesicants, both arsenical such as lewisite (CH.Cl: CH.As.Cl2) and also those of the mustard gas type. In this brief review, the main facts are given about the discovery of the antidote to lewisite known as BAL, owing to its medical importance; more detailed papers based upon the original reports are being prepared. An attempt is made to include the more relevant work from elsewhere and also to focus the main stages in this discovery, as this may prove useful in planning future work of this type.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
For review of Oxford work, see Peters, Lancet, 1, 1161 (1936), and Nature, 146, 387 (1940).
Nature, 138, 327 (1936).
Chem. Weekblad., 34, No. 26 (1937), and unpublished observations.
Onaka, Physiol. Chem., 70, 433 (1911). Szent-Gyrgyi, Biochem. J., 24, 1723 (1930). Voegtlin, Rosenthal and Johnson, U.S. Public Health Hep. 46, 339 (1931).
Krebs, Z. Physiol Chem., 217, 191 (1933).
McCleland and Peters, J. Physiol. Proc., 53, XV (1919).
Hopkins and Dixon, J. Biol. Chem., 54, 527 (1922).
Peters and Walker, Rep. to Government (1924).
Walker, Biochem. J., 19, 1085 (1925).
Walker, Biochem. J., 22, 292 (1928).
Voegtlin, Dyer and Leonard, U.S. Public Health Rep. 38, 1911.
U.S. Public Health Rep., 47, 241 (1932).
Dickens, Biochem. J., 27, 1141 (1933). Quastel and Wheatley, Biochem. J., 26, 2169 (1932). Rapkine, C.R. Soc. Biol., 112, 790 (1933).
J. Chem. Soc., 3043 (1931).
Sinclair, Thompson and Peters, Rep. to Min. of Supply by Peters, No. 3 (1940).
Thompson, R. H. S., and Johnson, R. E., Biochem. J., 29, 694 (1935).
Sinclair, H. M., Rep. to Min. of Supply by Peters, No. 27, and Peters (unreported).
Peters and Wakelin, Report circulated privately in U.K. and U.S. cf. âœPerspectives in Biochemistryâ (Cambridge) 1937, p. 41 (Jan. 1941).
Progress Report by Peters to Min. of Supply (Dec. 1940).
J. Pharm. Exp. Ther., 141, 148 (1939).
Ann. Trop. Med., 31, 387 (1937).
Report to Min. of Supply by Robinson (1940).
Goddard and Michaelis, J. Biol. Chem., 106, 605 (1934).
Stocken, L. A., and Thompson, R. H. S., Rep. to Min. of Supply by Peters, No. 20 (1940).
Stocken, Thompson and Whittaker, Rep. to Min. of Supply by Peters, No. 52 (1942).
Stocken and Thompson, Rep. to Min. of Supply by Peters, No. 29 (1941).
Vey, F., Porton Report (Fairley) (1941).
Mann and Pirie, Rep. to Min. of Supply by Marrian (1941). Cf. Robson and Scott, Rep. to Min. of Supply (1942) and Porton Reports (1943) by R. Leishman, G. I. Uhde and H. Davson and by E. B. Dunphy.
U.S. Reports (1942â1944).
Owen, Stranks, Vey, Davson, Leishman, Quilliam, Hartley and Fairley, Porton Report (1943).
U.S. Reports (1943).
Stocken and Thompson, Rep. to Min. of Supply by Peters, Nos. 20, 25, 29, 30, 33, 35, 36, 48, 52, also 64 and 65 (1943); also review by Peters, Stocken, Thompson and Whittaker, No. 69 (1943).
U.S. Report (1943).
Prepared by Stocken from BAL supplied by Min. of Supply.
Cambridge Rep. to Min. of Supply (1941).
Porton Reports (1944 and 1945).
Cambridge Reports; Van Heyningen. Rep. by Dixon to Min. of Supply, No. 10 (1942), No. 19 (1943), and Notes to Conference, Jan. 1943; also Mackworth (private communication) and U.S. Report (1942).
Rep. to Min. of Supply by Peters (1944), No. 78, and Whittaker, No. 89 (1945).
Spray, Stocken and Thompson, Rep. to Min. of Supply by Peters, No. 85 (1945). (See also, very recently, Simpson and Young., Canadian E.M. Report.)
Lovatt Evans, Porton Report. Levvy, Rep. to Min. of Supply by Marrian.
Rep. to Min. of Supply by Robinson (1942).
King and Pyman, J. Chem. Soc., 1238 (1914).
Rep. to Min. of Supply by Peters, No. 74.
Chiesman, Brit. Med. J., 2109 (1944), and Ferrie, A. M. (unpublished).
Interim Report to M.R.C. Carleton, Peters, Stocken, Thompson (Oxford); Williams (Netley); Storey, Levvy and Chance (Edinburgh).
(a) Graham and Chance, Rep. to Min. of Supply by Lewy (Feb. 1944). (b) Chance, Rep. to Min. of Supply by Levvy (June 1944).
Peters and Stocken, Rep. to Min. of Supply by Peters, No. 86 (1945).
Porton Report (1945).
Whittaker ; Stocken ; Reps. to Min. of Supply and Med. Res. Council by Peters, Nos. 91 and 92 (1945).
Note.-Reference to U.S. authors have been deleted by request of U.S. authorities.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
PETERS, R., STOCKEN, L. & THOMPSON, R. British Anti-Lewisite (BAL). Nature 156, 616–619 (1945). https://doi.org/10.1038/156616a0
Issue Date:
DOI: https://doi.org/10.1038/156616a0
This article is cited by
-
Arsenic in medicine: past, present and future
BioMetals (2023)
-
Arsenic: its chemistry, its occurrence in the earth and its release into industry and the environment
ChemTexts (2020)
-
Lipoic acid
ChemTexts (2019)
-
Metal chelators and neurotoxicity: lead, mercury, and arsenic
Archives of Toxicology (2017)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.
